Status:
WITHDRAWN
Probiotics in Irritable Bowel Syndrome
Lead Sponsor:
Meir Medical Center
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Probiotics are defined as 'mono- or mixed cultures of live micro-organisms which, when applied to animal or man, beneficially affect the host by improving the properties of the indigenous flora'. Cert...
Eligibility Criteria
Inclusion
- IBS by Rome III criteria
Exclusion
- other GI disease
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00846170
Start Date
September 1 2010
Last Update
March 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical center
Kfar Saba, Israel